ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0233

Lysozyme Nephropathy: An Underdiagnosed Cause of AKI

Session Information

Category: Onconephrology

  • 1700 Onconephrology

Authors

  • Prabhakar, Kiran Shankar, University of Louisville, Louisville, Kentucky, United States
  • Garg, Gunjan, University of Louisville, Louisville, Kentucky, United States

Group or Team Name

  • University of Louisville Nephrology.
Introduction

Lysozyme Nephropathy (LyN) is a rare and under-recognized cause of Acute Kidney Injury (AKI) in patients with hematologic malignancies. It is typically associated with Chronic Myelomonocytic Leukemia (CMML) due to overproduction of lysozyme by tumoral cells leading to proximal tubular cell injury. It is extremely rare, but, to-date reported cases in literature have demonstrated a wide spectrum and prognosis. Here we present a case of lysozyme nephropathy which was diagnosed at the same time as CMML and had renal recovery due to early diagnosis and timely initiation of treatment.

Case Description

70 yo M with PMH of DM, chronic colocutaneous fistula and COPD presented to the hospital due to abnormal outpatient labs. Patient complained of black urine for 1 wk. Outpatient labs showed WBC 106.5 x 10(3)/uL with diff 37% neutrophils, 10% bands, monocytes, and ~11% blasts. Hb was 6.3 mg/dL, platelet count 212 x 10(3)/uL , and Cr 3.35 mg/dL up from baseline of 1.0 mg/dL. UA showed >50 RBCs/hpf, 2+ proteinuria, UPCR was 1.46 g/g and renal USG showed no obstructive nephropathy. CT A/P showed splenomegaly of 18 cm. Due to worsening renal function, patient was started on hemodialysis (HD) and underwent renal biopsy which was significant for tubular injury with LyN. Bone marrow biopsy was performed and showed markedly hypercellular marrow with myeloid and megakaryocytic hyperplasia, with erythroid hypoplasia and dysmegakaryopoiesis. Flow cytometry revealed CD34 positive myeloid blasts around 3% of the cells. FISH analysis was positive for trisomy 8 but negative for BCR-ABL t(9;22), karyotypes 47 XY+8[20] confirming the diagnosis of CMML. Patient was treated with hydroxyurea and azathioprine. He had partial renal recovery within 4 weeks of initiating treatment and HD was discontinued.

Discussion

Lysozyme is a bactericidal enzyme synthesized in large amounts by neoplastic monocytes. LyN is seen in diseases with increased monocyte turnover such as underlying hematologic disorders. Although, few cases have been reported in literature, there is still paucity of awareness of this condition. Reporting of our case would add to the literature and improve awareness of LyN, hence leading to prompt diagnosis and treatment.

Digital Object Identifier (DOI)